AU5691699A - Human genes differentially expressed in colorectal cancer - Google Patents
Human genes differentially expressed in colorectal cancerInfo
- Publication number
- AU5691699A AU5691699A AU56916/99A AU5691699A AU5691699A AU 5691699 A AU5691699 A AU 5691699A AU 56916/99 A AU56916/99 A AU 56916/99A AU 5691699 A AU5691699 A AU 5691699A AU 5691699 A AU5691699 A AU 5691699A
- Authority
- AU
- Australia
- Prior art keywords
- colorectal cancer
- differentially expressed
- human genes
- genes differentially
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010009944 Colon cancer Diseases 0.000 title 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9863998P | 1998-08-31 | 1998-08-31 | |
US60098639 | 1998-08-31 | ||
US11739399P | 1999-01-27 | 1999-01-27 | |
US60117393 | 1999-01-27 | ||
PCT/US1999/019424 WO2000012702A2 (en) | 1998-08-31 | 1999-08-30 | Human genes differentially expressed in colorectal cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5691699A true AU5691699A (en) | 2000-03-21 |
Family
ID=26794949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56916/99A Abandoned AU5691699A (en) | 1998-08-31 | 1999-08-30 | Human genes differentially expressed in colorectal cancer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1108021A2 (de) |
JP (1) | JP2002523088A (de) |
AU (1) | AU5691699A (de) |
WO (1) | WO2000012702A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1637541B1 (de) * | 1999-09-01 | 2010-03-03 | Genentech, Inc. | Ausgeschiedene Polypeptide und Transmembranpolypeptide und dafür kodierende Nukleinsäuren |
US6953658B2 (en) | 2000-03-09 | 2005-10-11 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
WO2001073027A2 (en) * | 2000-03-24 | 2001-10-04 | Corixa Corporation | Compositions and methods for therapy and diagnosis of colon cancer |
AU2001263814A1 (en) * | 2000-03-27 | 2001-10-08 | Bayer Aktiengesellschaft | Regulation of human oatp2-related protein |
AU2001250405A1 (en) * | 2000-03-27 | 2001-10-08 | Bayer Aktiengesellschaft | Regulation of human adp-ribosylation factor-related protein |
WO2001072843A2 (en) * | 2000-03-27 | 2001-10-04 | Bayer Aktiengesellschaft | Regulation of human c-myb-related genes |
WO2001072955A2 (en) * | 2000-03-27 | 2001-10-04 | Bayer Aktiengesellschaft | Regulation of human nedd1-related protein |
EP1280901B1 (de) * | 2000-03-29 | 2005-01-26 | Max-Planck-Gesellschaft | Raumform von tpr-strukturmotiv enthaltenden polypeptiden mit chaperon-bindungsfunktion, deren kristalle und verbindungen zur inhibierung derartiger polypeptide |
EP1666497A3 (de) * | 2000-06-02 | 2006-06-21 | Genentech, Inc. | Polypeptide, dafür kodierende Nukleinsäuren, und deren Verwendung zur Diagnose von Krebs |
WO2002012280A2 (en) * | 2000-08-03 | 2002-02-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
WO2002012332A2 (en) * | 2000-08-07 | 2002-02-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US20040110668A1 (en) * | 2000-10-02 | 2004-06-10 | Burgess Christopher C. | Nucleic acid sequences differentially expressed in cancer tissue |
US20020137038A1 (en) * | 2000-12-04 | 2002-09-26 | Lasek Amy W. | Intestinal proteins |
US20050272120A1 (en) | 2001-06-20 | 2005-12-08 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
KR100628425B1 (ko) | 2001-06-20 | 2006-09-28 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물 |
US20030186302A1 (en) * | 2002-03-29 | 2003-10-02 | Yixin Wang | Colorectal cancer diagnostics |
JP2006517788A (ja) * | 2002-12-20 | 2006-08-03 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 15986、2188、20743、9148、9151、9791、44252、14184、42461、8204、7970、25552、21657、26492、2411、15088、1905、28899、63380、33935、10480、12686、25501、17694、15701、53062、49908、21612、38949、6216、46863、9235、2201、6985、9883、12238、18057、21617、39228、49928、54476、62113、64316、12264、32362、58198、2887、3205、8557、9600、9693、44867、53058、55556、57658、2208、10252、10302、14218、33877、10317、10485、25964、14815、1363、1397、14827、21708、3801、64698、2179または13249を使用する癌を処置するための方法および組成物 |
ATE370414T1 (de) | 2002-12-20 | 2007-09-15 | Hoffmann La Roche | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs |
JP4643450B2 (ja) | 2003-08-08 | 2011-03-02 | 株式会社ペルセウスプロテオミクス | 癌高発現遺伝子 |
DE10341812A1 (de) * | 2003-09-10 | 2005-04-07 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU625169B2 (en) * | 1987-03-23 | 1992-07-02 | Imperial Chemical Industries Plc | Molecular markers |
CA2175380A1 (en) * | 1993-10-29 | 1995-05-04 | Lan Bo Chen | A novel tumor marker and novel method of isolating same |
-
1999
- 1999-08-30 WO PCT/US1999/019424 patent/WO2000012702A2/en active Application Filing
- 1999-08-30 JP JP2000567689A patent/JP2002523088A/ja not_active Withdrawn
- 1999-08-30 AU AU56916/99A patent/AU5691699A/en not_active Abandoned
- 1999-08-30 EP EP99943918A patent/EP1108021A2/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000012702A3 (en) | 2000-09-08 |
EP1108021A2 (de) | 2001-06-20 |
WO2000012702A2 (en) | 2000-03-09 |
JP2002523088A (ja) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5691699A (en) | Human genes differentially expressed in colorectal cancer | |
AU2001294943A1 (en) | Nucleic acid sequences differentially expressed in cancer tissue | |
AU1922301A (en) | Differential gene expression in cancer | |
AU7499198A (en) | Gene expression profiles in normal and cancer cells | |
AU7721500A (en) | Colon and colon cancer associated polynucleotides and polypeptides | |
AU1132595A (en) | Chromosome 18q loss and prognosis in colorectal cancer | |
AU1344400A (en) | Inflammation-associated genes | |
IL206604A0 (en) | Transmembrane protein expressed in prostate cancer | |
AU1453301A (en) | Methods of reversing drug resistance in cancer cells | |
AU2452197A (en) | Genes amplified in cancer cells | |
AU7058000A (en) | 13 human colon and colon cancer associated proteins | |
AU2890199A (en) | Gata-3-expression in human breast carcinoma | |
AU5340699A (en) | Human anion transporter genes atnov | |
AU2238499A (en) | Androgen-metabolic gene mutations and prostate cancer risk | |
AU8026300A (en) | Sodd gene expression in cancer | |
AU2001226922A1 (en) | Cancer associated genes and their products | |
AU7089800A (en) | 29 human cancer associated proteins | |
AU9071098A (en) | Breast cancer resistance genes, methods for their detection and uses thereof | |
AU2506499A (en) | Cea/nca-based differentiation cancer therapy | |
AU2674599A (en) | A novel npg-1 gene that is differentially expressed in prostate tumors | |
AU2002215111A1 (en) | Ruthenium-aryl-compounds in cancer therapy | |
AU5416700A (en) | Differentially expressed genes in prostate cancer | |
AU2002217984A1 (en) | Erythropoietin and erythropoietin receptor expression in human cancer | |
AU6111800A (en) | 26 human prostate and prostate cancer associated proteins | |
AU3549799A (en) | Mammalian selenoprotein differentially expressed in tumor cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |